Shannon Thyme Klinger serves as the Chief Legal Officer and Corporate Secretary at Moderna, Inc., a leading biotechnology company focused on developing messenger RNA (mRNA) therapeutics and vaccines. In her role, Klinger is responsible for overseeing all legal matters at Moderna, including corporate governance, intellectual property, compliance, and litigation. As Corporate Secretary, she also plays a critical role in managing the company's board of directors and ensuring effective communication between the board and management. Prior to joining Moderna in 2018, Klinger had an impressive career in the legal field, with a strong background in life sciences and healthcare. She spent over a decade at Goodwin Procter LLP, a prominent law firm, where she was a partner in the Life Sciences group. During her time at Goodwin, Klinger advised numerous biotechnology and pharmaceutical companies on a wide range of legal issues, including mergers and acquisitions, licensing agreements, and securities offerings. Her expertise in navigating complex legal landscapes in the life sciences industry has been invaluable to Moderna as the company continues to grow and innovate. As Chief Legal Officer at Moderna, Klinger has played a pivotal role in the company's success, particularly during the development and global distribution of its COVID-19 vaccine. Her leadership and strategic guidance have been essential in ensuring that Moderna can effectively manage legal challenges while maintaining a focus on its mission to deliver transformative medicines to patients. Klinger's dedication to Moderna's values and her ability to foster a culture of integrity and compliance have made her an integral part of the company's leadership team.